Effects of Terlipressin on Management of Potential Organ Donors

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 1, 2018

Study Completion Date

March 12, 2018

Conditions

Organ Donors

Interventions

DRUG

terlipressin

a continuous infusion of terlipressin (0.4 mg/kg/h) was initiated

All Listed Sponsors

lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT03477461 - Effects of Terlipressin on Management of Potential Organ Donors | Biotech Hunter | Biotech Hunter